  Purpose: In this study, we present the creation of an anthropomorphic, head
and neck, nuclear medicine phantom and its characterization for the validation
of a Monte Carlo, SPECT image based, Iodine-131 RPT dosimetry workflow.
  Methods: 3D printing techniques were used to create the anthropomorphic
phantom from a patient CT dataset. Three Iodine-131 SPECT/CT imaging studies
were performed using a homogeneous, Jaszczak, and an anthropomorphic phantom to
quantify the SPECT images. The impact of collimator detector response (CDR)
modeling and volume-based partial volume corrections (PVC) upon the absorbed
dose was calculated using an image based, Geant4 Monte Carlo RPT dosimetry
workflow and compared against a ground truth scenario. Finally, uncertainties
were quantified in accordance with recent EANM guidelines.
  Results: The 3D printed anthropomorphic phantom was an accurate re-creation
of patient anatomy including bone. The extrapolated Jaszczak recovery
coefficients were greater than that of the 3D printed insert (~22.8 ml) for
both the CDR and non-CDR cases. Utilizing Jaszczak phantom PVCs, the absorbed
dose was underpredicted by 0.7% and 4.9% without and with CDR, respectively.
Utilizing anthropomorphic phantom RCs overpredicted the absorbed dose by 3%
both with and without CDR. All dosimetry scenarios that incorporated PVC were
within the calculated uncertainty of the activity. The uncertainties in the
cumulative activity ranged from 25.6% to 113% for Jaszczak spheres ranging in
volume from 0.5 ml to 16 ml.
  Conclusion: The accuracy of Monte Carlo-based dosimetry for Iodine-131 RPT in
head and neck cancer was validated with an anthropomorphic phantom. Future
applications of the phantom could involve 3D printing and characterizing
patient specific volumes for more personalized RPT dosimetry estimates.
